When was Cepheid founded?

Cepheid was founded in 1996 and raised its 1st funding round 4 years after it was founded.

Where is Cepheid located?

Cepheid is headquartered in Sunnyvale, United States. It is registered at 9th Floor, Paras Twin Towers, Tower B Golf Course, Sec-54, Gurgaon, Gurugram, Haryana, India, 122002.

How many employees does Cepheid have?

As of Aug 31, 2026, the latest employee count at Cepheid is 4645.

Is Cepheid a funded company?

Cepheid is a funded company, having raised a total of $19.1M across 10 funding rounds to date. The company's 1st funding round was a $***** Series C round, raised on Jan 21, 2000.

How much is Cepheid worth?

The last known valuation of Cepheid was $***** as of Sep 06, 2016.

When was the latest funding round of Cepheid?

Cepheid's latest funding was a $***** Grant (prize money) round on Jul 30, 2021, with participation from 1 investor.

What is the annual revenue of Cepheid?

Annual revenue of Cepheid is between $500M and $1B as on Dec 31, 2015

Where does Cepheid rank among its competitors?

Cepheid ranks 3rd amongst 870 active competitors, of which 81 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Agilent, which secured $432K in Dec, 2023.

Who are the top competitors of Cepheid?

Cepheid's top competitors include Siemens Healthineers, Agilent and Illumina. Among them, Agilent secured the most recent funding round in December, 2023.

Cepheid - 2026 Company Profile, Team, Funding, Competitors & Financials

Q: Is Cepheid an acquired company?

Cepheid got acquired by Danaher on Sep 06, 2016.

Company Details

Developer of molecular diagnostic testing solutions. The company offers a wide range of tests segregated into three major categories Hospital-acquired infection, Critical Infectious diseases (multi-drug resistant TB (MDR-TB), influenza, RSV, and Enteroviral meningitis) Sexual Health, and Genetic Test (30 Minute Test for Genetic Risk of Thrombosis).

Website: www.cepheid.com/en-US.html
Social
Registered Address: 9th Floor, Paras Twin Towers, Tower B Golf Course, Sec-54, Gurgaon, Gurugram, Haryana, India, 122002

Key Metrics

Founded Year

1996

Location

Sunnyvale, United States

Stage

Acquired

Total Funding

$19.1M in 10 rounds

Latest Funding Round

Grant (prize money), Jul 30, 2021, $*****

Last Known Valuation

$***** as on Sep 06, 2016

Investors

CampVentures & 15 more

Ranked

3^rd among 870 active competitors

Annual Revenue

$500M - $1B as on Dec 31, 2015

Employee Count

4,645 as on Aug 31, 2026

Investment & Acquisitions

OncoMark

Similar Companies

Agilent & 577 more

Exit Details

Acquired by Danaher (Sep 06, 2016)

View Cepheid's full profile

Cepheid is associated with 4 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Cepheid CIN: 17704416258 , United States, Active		-	-	-
Cepheid Denmark ApS CIN: 42493139 , Denmark, Active	Jun 24, 2021	-	-
CEPHEID CIN: 1037760 , United States, Active	Dec 26, 2021	$500M - $1B (As on Dec 31, 2015)	1479 (As on Dec 31, 2017)	-
CEPHEID INDIA PRIVATE LIMITED CIN: U33110HR2013FTC099516 , India, Active	Aug 22, 2013	₹500 - ₹1,000 Cr (As on Mar 31, 2025)	180 (As on Mar 01, 2026)

Cepheid got acquired by Danaher on Sep 06, 2016 at an acquisition amount of $*****.

Click here to take a look at Cepheid's acquisition in detail

Cepheid has raised a total funding of $19.1M over 10 rounds. Its first funding round was on Jan 21, 2000. Its latest funding round was a Grant (prize money) round on Jul 30, 2021 for $*****. 1 investor participated in its latest round. Cepheid has 16 institutional investors.

Here is the list of recent funding rounds of Cepheid:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 30, 2021	5070479	Grant (prize money)	1649208	4115779	5183207	2493636
Sep 20, 2014	7482831	Grant (prize money)	4565736	9387065	8104940	USAID
Feb 07, 2013	5771913	Grant (prize money)	8217570	7684330	4940591	Military Health

Access funding benchmarks and valuations. Sign up today!

View details of Cepheid's funding rounds and investors

The founders of Cepheid are Kurt Petersen and Steve Young.

Here are the details of Cepheid's key team members:

Kurt Petersen: Founder, President, CTO of Cepheid and founder of 1 other company. They are also an angel investor in 1 startup.
Steve Young: Co-Founder of Cepheid and founder of 3 other companies, UDP Labs, BAM Labs and GetMyHomesValue.com.

View details of Cepheid's Founder profiles and Board Members

Cepheid's employee count trend

Cepheid has 4,645 employees as of Aug 26. Here is Cepheid's employee count trend over the years:

Uncover Cepheid's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cepheid include Siemens Healthineers, Agilent and Illumina. Here is the list of Top 10 competitors of Cepheid, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Siemens Healthineers 2017, Forchheim (Germany), Public	Provider of medical imaging laboratory diagnostics and clinical digital solutions	-	Qatar Investment Authority, Skyviews Life Science ... & 3 others	75/100
2nd	Agilent 1995, Santa Clara (United States), Public	Developer of diversified instruments for scientific and laboratory management	-	Smile Incubator, JANA Partners & 6 others	73/100
3rd	Cepheid 1996, Sunnyvale (United States), Acquired	Developer of molecular diagnostic testing solutions	$19.1M	CampVentures, Medtronic & 14 others	73/100
4th	Illumina 1993, San Diego (United States), Public	Developer of technologies for analysis of genetic variation and function	$28M	Chevron Technology Ventures, Dow Chemical Company ... & 32 others	71/100
5th	Quanterix 2007, Cambridge (United States), Public	Developer of assay kits for ultra-sensitive biomarker detection	$99.5M	T. Rowe Price, Novalis LifeSciences & 15 others	71/100
6th	Bruker 1960, United States, Public	Manufacturer of high-performance scientific instruments for life sciences	-	Essex Investment Management, European Innovation Council ... & 5 others	70/100
7th	Sartorius 1870, Gottingen (Germany), Public	Developer of laboratory and biopharmaceutical equipment	-	Eiffel Investment Group, Juno Investment Partners ... & 2 others	70/100
8th	Unchained Labs 2015, Pleasanton (United States), Acquired	Developer of multiplex protein stability platform for biologics	$111M	Canaan, Novo Holdings & 6 others	68/100
9th	Esco Lifesciences 1978, Singapore (Singapore), Late Stage	Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools	$200M	Vivo Capital, Novo Holdings & 3 others	67/100
10th	BioLife Solutions 1987, Bothell (United States), Acquired	Developer of cell and gene therapies with the integrity of a single cell	-	-	67/100